A recent study explored TP53 expression in AML blasts with normal karyotype showing that 24% of these leukemias display TP53 protein overexpression, associated with absent CD34 expression on leukemic blasts and presence of FLT3-ITD mutations [311]. This evidence concerns the gene CD34 and leukemia.